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The molecular pathways involved in methylmercury (MeHg)-induced neurotoxicity are not
fully understood. Since pan-Histone deacetylases (HDACs) inhibition has been found to
revert the neurodetrimental effect of MeHg, it appeared of interest to investigate whether
the pattern of HDACs isoform protein expression is modified during MeHg-induced
neurotoxicity and the transcriptional/transductional mechanisms involved. SH-SY5Y
neuroblastoma cells treated with MeHg 1 µM for 12 and 24 h showed a significant
increase of HDAC4 protein and gene expression, whereas the HDACs isoforms 1–3,
5, and 6 were unmodified. Furthermore, MeHg-induced HDAC4 increase was reverted
when cells were transfected with siRNAs against specificity protein 1 (Sp1) and
Sp4, that were both increased during MeHg exposure. Next we studied the role of
extracellular-signal-regulated kinases 1/2 (ERK1/2), c-Jun N-terminal kinases (JNK), and
p38 mitogen-activated protein kinases (MAPKs) in MeHg—induced increase of Sp1,
Sp4, and HDAC4 expression. As shown by Western Blot analysis MeHg exposure
increased the phosphorylation of p38, but not of ERK and JNK. Notably, when p38 was
pharmacologically blocked, MeHg-induced Sp1, Sp4 protein expression, and HDAC4
protein and gene expression was reverted. In addition, MeHg exposure increased the
binding of HDAC4 to the promoter IV of the Brain-derived neurotrophic factor (BDNF)
gene, determining its mRNA reduction, that was significantly counteracted by HDAC4
knocking down. Furthermore, rat cortical neurons exposed to MeHg (1 µM/24 h) showed
an increased phosphorylation of p38, in parallel with an up-regulation of Sp1, Sp4, and
HDAC4 and a down-regulation of BDNF proteins. Importantly, transfection of siRNAs
against p38, Sp1, Sp4, and HDAC4 or transfection of vector overexpressing BDNF
significantly blocked MeHg-induced cell death in cortical neurons. All these results
suggest that p38/Sp1-Sp4/HDAC4/BDNF may represent a new pathway involved in
MeHg-induced neurotoxicity.
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INTRODUCTION
Exposure to MeHg is detrimental, particularly for the developing
brain (Ceccatelli et al., 2013). Indeed prenatal poisoning with
high dose of MeHg causes mental retardation and cerebral
palsy (Myers and Davidson, 1998). Regarding the possible
relationship between MeHg exposure and the development of
neurodegenerative disorders, in in vitro studies it has been found
that MeHg can induce Parkinson’s-like neurotoxicity similar
to 1-methyl-4- phenylpyridinium (Shao et al., 2015), and in
vivo it hastens the onset of amyotrophic lateral sclerosis-like
phenotype in G93A mice (Johnson et al., 2011). Several reports
have suggested that HDACsmay play a role in neurodegenerative
disease and might be involved in the neurotoxic effects
of environmental pollutants. In particular, among the zinc-
dependent HDAC family members, composed of class I (HDACs
1, 2, 3, and 8), classes IIa and IIb (HDACs 4, 5, 6, 7, 9, and
10), or class IV (HDAC 11), that are all expressed in the brain
(Volmar andWahlestedt, 2015), only the isoforms 1–6 seem to be
involved in neurotoxicity. In fact, it has been demonstrated that
HDACs 1, 2, and 4 exert a neurotoxic effect after brain ischemia
(Formisano et al., 2015b; Yuan et al., 2016), HDAC3 and HDAC5
can induce cell death of cerebellar granule neurons (CGN)
(Bardai and D’Mello, 2011), and HDAC6 inhibition protects
against oxidative stress-induced neurodegeneration (Rivieccio
et al., 2009). On the other hand a pan HDAC inhibition has been
found to be neuroprotective in vitro against the neurotoxicity
of bis (2-ethylhexyl) phthalate (DEHP) (Guida et al., 2014),
Polychlorinated Biphenyls (PCB) (Formisano et al., 2011, 2015a),
and MeHg (Guida et al., 2015b). Recently, it has also been shown
that the mercury-containing organic compound Thimerosal
induces an increase of the HDAC4 isoform (Guida et al.,
2015b, 2016) determining neuronal cell death, but the molecular
mechanism of this effect is still unrevealed. On the other hand,
it is known that HDAC4 mRNA expression is regulated by the
transcription factors specificity proteins 1 (Sp1) and 3 (Sp3) (Liu
et al., 2006), that have been also associated in vivo to neuronal
cell death after stroke (Formisano et al., 2015b), and in vitro
to cell death after PCB exposure, through the up-regulation of
RE1-Silencing Transcription factor (REST) (Formisano et al.,
2015c). These findings prompted us to investigate whether
HDAC4 is the only isoform involved in MeHg-induced neuronal
cell death and the molecular mechanisms responsible for its
increase. Furthermore, since it has been demonstrated that male
mice offspring of mothers chronically exposed to MeHg show
persistent behavioral changes, associated to lower expression
of brain-derived neurotrophic factor (BDNF) mRNA in the
hippocampal dentate gyrus (DG) (Ceccatelli et al., 2013), and that
MeHg exposure causes a concentration dependent decrease of
serum BDNF in girls born from nonsmoking mothers (Spulber
et al., 2010), we investigated whether among the HDAC4 target
genes, the BDNF could be involved in neuronal cell death
evoked by MeHg. At last in the present study we found that
MeHg increases specifically HDAC4 expression in SH-SY5Y
nuroblastoma cells and in rat cortical neurons and its toxic
effect is due to the triggering of the p38/Sp1-Sp4/HDAC4/BDNF
pathway.
MATERIALS AND METHODS
Drug and Chemicals
Methylmercury (II) chloride (MeHg) (cod: 442534 stock solution
100 µM) and p38 inhibitor SB239063 (SB) (cod: 559404 stock
solution 10 mM) were both dissolved in vehicle as previously
reported (Sirabella et al., 2012; Guida et al., 2015b). Culturemedia
and sera were purchased from Invitrogen (Milan, Italy). In all
experiments, the control group (CTL) was treated with vehicle.
Cell Cultures and Small Interfering RNAs
(siRNAs) and Constructs Transfections
SH-SY5Y human neuroblastoma cells and rat cortical neurons
(DIV 7) were cultured as previously reported (Formisano
et al., 2013). Importantly, to avoid glial contamination the
glial inhibitor cytosine arabinoside (2.5 µM) was added at the
second day of seeding (Formisano et al., 2013). The experiments
on primary cortical neurons were performed according to the
experimental protocols approved by the Ethics Committee of
“Federico II” University of Naples. SH-SY5Y cells were incubated
in a low serum medium (Guida et al., 2015b) and treated with
MeHg 1 µM at 12 and 24 h. For dose-dependent experiments,
primary cortical neurons were treated for 24 h with MeHg at
0.1, 0.5, 1, and 3 µM. For SB239063 experiments cells were
pre-treated for 2 h with the drug at 10 µM followed with
MeHg 1 µM for 24 h. All transfection experiments in SH-
SY5Y and cortical neurons were performed 24 h before MeHg
treatment (1 µM/24 h) with HiPerFect Transfection Reagent
(Quiagen) in accordance with the manufacture’s protocol, as
previously reported (Vinciguerra et al., 2014). In SH-SY5Y cells
and cortical neurons the synthetic small interfering RNA (siRNA)
transfections for Sp1 (siSp1), HDAC4 (siHDAC4), and negative
control (siCTL) were performed as already reported (Formisano
et al., 2015b; Guida et al., 2016). In particular, siRNAs against
Sp1 reduced Sp1 protein expression respectively of 80 and 68%
in SH-SY5Y cells and rat cortical neurons, as already published
(Formisano et al., 2015b). Whereas, siRNAs against HDAC4
reduced HDAC4 protein expression respectively of 75 and 71%
in SH-SY5Y cells and rat cortical neurons, as already published
(Guida et al., 2016). They were also transfected with siRNAs
against human and rat Sp4 (siSp4; SI04333588) at 20 nM, both
purchased from Quiagen. For BDNF overexpression cortical
neurons were transfected with 15 µg of plasmid pCMV6 BDNF
(BDNF), that was a gift from Yves-Alain Barde (Addgene plasmid
#39857, (Hofer et al., 1990), or with the empty vector pCMV6
(mock), using Lipofectamine in Optimem for 2 h 24 h before
MeHg treatment (1 µM/24 h). The number of cells and the
efficiency of transfection was the same as reported in other
studies (Formisano et al., 2015b).
Determination of Cell Vitality
Neuronal vitality was evaluated by measuring lactate
dehydrogenase (LDH) eﬄux into the medium after cortical
neurons have been treated with MeHg for 24 h at concentrations
of 0.1, 0.5, 1, and 3 µM. LDH was determined with LDH
Cytotoxicity Kitfrom Cayman, DBA (Milan, Italy), as previously
reported (Formisano et al., 2015b). Cell lysate, prepared with 1%
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Triton X-100 (Sigma-Aldrich), was used as a positive control,
and its value was considered 100%.
For the experiments with siRNAs (sip38, siSp1, siSp4, and
siHDAC4), neurons were transfected with siRNAs 24 h before
MeHg treatment (1 µM/24 h). Cell viability was measured by
MTT assay as previously described (Guida et al., 2015a, 2016).
Chromatin Immunoprecipitation (ChIp)
Assay and Quantitative Reverse
Transcription Polymerase Chain Reaction
(qRT-PCR) Analysis
ChIP assay in SH-SY5Y cells was performed as previously
reported (Guida et al., 2015a). The antibodies for
immunoprecipitation are: anti-Sp1 (sc- 14027 Santa Cruz
Biotechnology), anti-Sp4 (sc- 645 Santa Cruz Biotechnology),
and anti-HDAC4 (sc- 11418 Santa Cruz Biotechnology), all used
at 3 µg. The specificity of antibodies used for ChIP assays has
been confirmed by our group and others (Saramäki et al., 2009;
de Nigris et al., 2010; Johar et al., 2013; Formisano et al., 2015b)
where it has been found with this technique that Sp1, Sp4, and
HDAC4 are bound to the promoter sequences of their target
genes. Furthermore, since the antibodies used were all rabbit
polyclonal, in all the experiments Rabbit IgG antibody (sc-2345
Santa Cruz Biotechnology) was used as a negative control (data
not shown). Two-microliter aliquots (in duplicate for each
treatment group) were used for PCR with Fast SYBR green
master mix (Applied Biosystems). Data obtained from three
different PCR experiments were expressed as a percentage of the
control, all normalized for the DNA input. The oligonucleotides
used for the amplification of immunoprecipitated DNA of
HDAC4 promoter and BDNF promoter IV sequences were
already published (Liu et al., 2006; Sen et al., 2015). For
qRT-PCR analysis, endogenous RNA (2 µg) from SH-SY5Y
was isolated according to the supplier’s protocol (Tri reagent;
Sigma-Aldrich) and treated with DNAseI (1 U/µl) for 15 min
at room temperature. Retrotranscription and q-PCR reaction
were performed as already published (Formisano et al., 2015c).
Primer pairs for human HDAC4, L19 ribosomal protein (L19)
and BDNF splicing isoform IV were already published (Guida
et al., 2014; Sen et al., 2015). Three independent samples were
amplified simultaneously in triplicate in one assay run, and
the threshold cycle (Ct) value for each experimental group was
determined. L19 was used for normalization and differences
among groups was evaluated with the 2−11ct formula.
Immunoblotting
Cell lysates from cortical neurons and SH-SY5Y cells were
prepared via scraping on ice and pelleting at 4◦C, followed
by resuspension in lysis buffer (50mM Tris-HCl (pH 7.5),
150 mM NaCl, 1% NP-40, 1 mM EDTA, 10mM sodium
pyrophosphate, 1mM sodium orthovanadate, 100mM NaF,
1mM PMSF and protease inhibitor cocktail), and kept in
ice for 1 h. After that cells were centrifuge at 14,000 rpm
and protein concentration in the supernatant was quantified
by Bradford method and resuspended in lamely buffer. For
immunoblotting, 100 µg of sample for BDNF and 50 µg of
sample for all other proteins were separated via SDS-PAGE and
transferred to PVDF membranes. After transfer, the membranes
were blocked for 2 h at room temperature with 5% non-fat
milk in phosphate-buffered saline (PBS) and then incubated at
the dilution of 1:1000 in 5% non-fat milk with the following
primary antibodies: anti-Sp1, anti-Sp3, anti-Sp4, anti P-ERK,
anti-ERK-, anti P-p38, anti-p38, anti P-JNK, anti-JNK, anti-
HDAC1, anti-HDAC2, anti-HDAC3, anti-caspase 3, anti-α-
tubulin and anti-β-actin, that were already used (Formisano
et al., 2015a,b; Guida et al., 2015b), anti-HDAC4 (cod. sc-11418,
1:1000 polyclonal rabbit antibody; Santa Cruz Biotechnology),
anti-HDAC5 (cod. sc-11419, 1:1000 polyclonal rabbit antibody;
Santa Cruz Biotechnology), anti-HDAC6 (cod. sc-11491, 1:1000
polyclonal goat antibody; Santa Cruz Biotechnology). β-actin
or α-tubulin were used as the loading control for all the
experiments. After that the membrane were washed with PBS
with 0.1% Tween, and finally were probed with secondary
antibodies. The membranes were exposed to film after enhanced
chemiluminescence (ECL) (Amersham Biosciences, Piscataway,
NJ). Quantitative analysis of immunoblots was performed from
images with unsaturated conditions and quantized with Image J
software.
Statistical Analysis
For the analysis of more than two experimental groups was used
ANOVA followed by Turkey’s test as the post-hoc test, whereas
for the analysis of two experimental groups was used Student’s
t-test. Details of the statistical analyses are described in the figure
legends.
RESULTS
MeHg Up-Regulates HDAC4 mRNA and
Protein
Since it has been found in SH-SY5Y cells that HDAC-inhibition
reverts the neurodetrimental effect of MeHg at 1 µM/24 h
(Guida et al., 2015b), we evaluated the protein levels of the
neurotoxic HDAC isoforms 1–6 (Rivieccio et al., 2009; Bardai
and D’Mello, 2011; Formisano et al., 2015b; Yuan et al., 2016)
performing Western blot after treating cells with MeHg for 24 h.
MeHg (1µM) significantly increased HDAC4, but not HDACs
1,2,3, and 5,6 (Figures 1A–F). In addition, qRT-PCR analysis
revealed that MeHg-induced HDAC4 increase occurred also at
transcriptional level at 12 and 24 h (Figure 1G).
MeHg-Induced HDAC4 mRNA and Protein
Increase Is Determined by Sp1 and Sp4
Up-Regulation
Since HDAC4 expression can be regulated by Sp family
transcription factors (Liu et al., 2006), we evaluated the effect of
MeHg exposure on the expression of Sp1, Sp3, and Sp4 in SH-
SY5Y cells. In these cells at 12 and 24 h MeHg (1 µM) induced
an increase in Sp1 and Sp4, but not Sp3 protein expression
(Figures 2A–C). Importantly, as revealed by ChIP experiments,
Sp1 and Sp4 increase occurred also at level of HDAC4 gene
promoter sequence (Figures 2D,E). To evaluate the effect of Sp
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FIGURE 1 | Effect of 24h of Methylmercury (1µM) on HDACs protein expression. (A–F) Western blots of HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, and
HDAC6 in SH-SY5Y cells treated for 24 h with MeHg (1 µM). Bars represent the mean ± S.E.M. obtained from three independent experiments. Asterisk symbols on
columns indicate differences between control (CTL) and MeHg. *p ≤ 0.05 (unpaired t-test). (G) qRT-PCR of HDAC4 in SH-SY5Y treated for 12 or 24 h with MeHg
(1µM). Graphs show quantification of ratio of HDAC4 to L19. Bars represent mean ± S.E.M. obtained from three independent experiments. Asterisk symbols on
columns indicate differences between CTL and MeHg treatment. *p ≤ 0.05 (one-way ANOVA with Turkey’s post-hoc test).
transcription factors on HDAC4 mRNA and protein expression
levels after MeHg treatment, SH-SY5Y cells were silenced with
siRNAs against Sp1 (siSp1) and Sp4 (siSp4). The effect of siSp1 on
Sp1 protein expression it has been already published (Formisano
et al., 2015c), whereas siSp4 reduced Sp4 protein expression
by 60% compared to cells transfected with siCTL (data not
shown). Interestingly, as shown in Figures 2F,G, siSp1 and siSp4
significantly blockedMeHg-induced HDAC4mRNA and protein
increase.
MeHg-Induced HDAC4 mRNA and Protein
Up-Regulation Is due to an Increase of p38
Phosphorylation That Increases Sp1 and
Sp4 Binding on HDAC4 Promoter
Sequence
As MeHg induces the phosphorylation of ERK1/2 and p38, but
not of JNK (Lu et al., 2011), we investigated whether MeHg-
induced Sp1 and Sp4 up-regulation occurred via the activation
of a specific MAP Kinase. In these cells, MeHg (1 µM) at
12 and 24 h caused an increase of p38 phosphorylation, but
not of ERK 1/2 and JNK (Figures 3A–C). Interestingly, in cells
exposed toMeHg, pre-treatment with the p38 inhibitor SB239063
significantly counteracted the increase of Sp1 and Sp4 protein
expression (Figures 3D,E). To evaluate whether the increase in
p38 phosphorylation following MeHg exposure could contribute
to increases in HDAC4 mRNA and protein expression through
Sp1 and Sp4, we performed a ChIP assays on HDAC4 promoter
sequence for Sp1 and Sp4, and qRT-PCR and Western blotting
experiments to analyze the modifications of HDAC4 mRNA
and protein. As shown in Figures 3F–H, SB239063 treatment
reduced MeHg-induced binding of Sp1 and Sp4 to the HDAC4
gene promoter sequence with consequent reduction of MeHg-
increased HDAC4 mRNA and protein expression.
p38/Sp1/Sp4 Increase the Binding of
HDAC4 on BDNF Promoter IV Sequence
Determining Its mRNA and Protein
Reduction
Given that the HDAC4 gene target BDNF expression has been
correlated to MeHg exposure (Spulber et al., 2010; Ceccatelli
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FIGURE 2 | Sp1 and Sp4 increase and bind HDAC4 gene promoter sequence, determining its up-regulation in SH-SY5Y treated with MeHg (1 µM).
(A–C) Western blotting of Sp1, Sp3, and Sp4 in SH-SY5Y cells treated with 1 µM of MeHg for 12 and 24 h. Bars represent the mean ± S.E.M. obtained from three
independent experiments. Asterisk symbols on columns indicate differences between CTL and MeHg treatment. *p < 0.05 (one-way ANOVA with Turkey’s post-hoc
test). (D,E) ChIP analysis of the Sp1 sites on HDAC4 gene promoter regions carried out with anti-Sp1 and anti-Sp4, in SH-SY5Y cells treated with 1 µM of MeHg for
12 and 24 h. The binding activity of Sp1 and Sp4 is graphically represented as the percentage of the control (CTL). Each column represents the mean ± S.E.M
(n = 3). Asterisk symbols on columns indicate differences between CTL and MeHg treatment. **p < 0.01, *p < 0.05 (one-way ANOVA with Turkey’s post-hoc test). (F)
qRT-PCR of HDAC4 in SH-SY5Y transfected with siRNA for Sp1 (siSp1) and for Sp4 (siSp4) and treated with MeHg (1 µM/24 h). Graphs show quantification of ratio
of HDAC4 to L19. Bars represent mean ± S.E.M. obtained from three independent experiments. Asterisk symbols on columns indicate differences between siCTL
and MeHg. Asterisk symbols on brackets indicate significance compared to MeHg. ****p < 0.0001 (one-way ANOVA with Turkey’s post-hoc test). (G) Western blotting
of HDAC4 in SH-SY5Y transfected with siRNA for Sp1 (siSp1) and for Sp4 (siSp4) and treated with MeHg (1 µM/24 h). Bars represent the mean ± S.E.M. obtained
from three independent experiments. Asterisk symbols on columns indicate differences compared to siCTL+MeHg. **p < 0.01, *p < 0.05 (one-way ANOVA with
Turkey’s post-hoc test).
et al., 2013), that in SH-SY5Y cells the BDNF exon IV and VI
splicing isoforms represent the most highly expressed transcripts
(Donnici et al., 2008), and that only BDNF promoter IV (BDNF
pIV) activity is repressed by HDAC4 (Koppel and Timmusk,
2013), and we investigated the effect of MeHg at 24 h on the
BDNF exon IV expression. As shown in Figures 4A,B MeHg
reduced BDNF exon IV expression, in parallel with an increase of
HDAC4 binding on BDNF promoter IV sequence. Furthermore,
we studied the role of p38/Sp1/Sp4/HDAC4 pathway in the
modulation of HDAC4 binding on BDNF pIV sequence and
on BDNF IV mRNA expression. Interestingly, as shown in
Figure 4C, MeHg determined an increase of HDAC4 binding
on BDNF pIV, that was counteracted when cells were pretreated
with SB239063, or transfected with siRNAs against Sp1, Sp4, and
HDAC4. As expected, we found that MeHg-induced reduction
of BDNF mRNA was blocked when cells were pretreated with
SB239063, or transfected with siRNAs against Sp1, Sp4, and
HDAC4 (Figure 4D).
MeHg Exposure Induces Cell Death by
Activation of p38/Sp1/Sp4/HDAC4/BDNF
Axis in Cortical Neurons
Cortical neurons were exposed to MeHg (0.1–3 µM; Figure 5A)
for 24 h. As shown in Figure 5A a dose-related increase
in cell death was observed, as evidenced by LDH assay,
and 1 µM was the concentration of MeHg that determined
cell death by about 50% and was therefore chosen for all
the experiments in cortical neurons. Notably, MeHg induced
an increase of P-p38, Sp1, Sp4, HDAC4 in parallel with a
reduction of BDNF protein (Figures 5B–F). Then we studied
the role of P-p38/Sp1/Sp4/HDAC4/BDNF pathway in MeHg-
induced cell death. To this aim, we knocked down p38,
Sp1, Sp4 and HDAC4, by transfecting neurons with specific
siRNAs named sip38, siSp1, siSp4, and siHDAC4 and increased
BDNF with a plasmid overexpressing BDNF named pBDNF.
Notably, the efficiency of sip38, siSp1, and siHDAC4 to
reduce respectively p38, Sp1, and HDAC4 protein expression
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FIGURE 3 | p38 MAPK inhibitor SB239063 reverts Sp1 and Sp4 protein expression increase and blocks their binding on HDAC4 promoter sequence
and its down-regulation. (A–C) Western blotting of P-ERK1/2, P-p38, and P-JNK in SH-SY5Y cells treated with 1 µM of MeHg for 12 and 24 h. Bars represent the
mean ± S.E.M. obtained from three independent experiments. Asterisk symbols on columns indicate differences between CTL and MeHg. **p < 0.01 (one-way
ANOVA with Turkey’s post-hoc test). (D,E) Western blotting of Sp1 and Sp4 in SH-SY5Y cells treated with MeHg (1 µM/24 h), alone or in combination with SB239063
(SB). Bars represent the mean ± S.E.M. obtained from three independent experiments. Asterisk symbols on columns indicate differences compared to CTL. Asterisk
symbols on brackets indicate significance between MeHg and SB. **p < 0.01, *p < 0.05 (one-way ANOVA with Turkey’s post-hoc test). (F,G) ChIP analysis of the Sp1
sites on HDAC4 gene promoter regions carried out with anti-Sp1 and anti-Sp4, in SH-SY5Y cells treated with MeHg (1 µM/24 h), alone or in combination with SB.
The binding activity of Sp1 and Sp4 is graphically represented as the percentage of the control. Each column represents the mean ± S.E.M (n = 3). Asterisk symbols
on columns indicate differences between control CTL and MeHg. Asterisk symbols on brackets indicate significance between MeHg and SB+MeHg. **p < 0.01,
*p < 0.05 (one-way ANOVA with Turkey’s post-hoc test). (H) Western blotting of HDAC4 in SH-SY5Y cells treated with MeHg (1 µM/24 h), alone or in combination
with SB. Bars represent the mean ± S.E.M. obtained from three independent experiments. Asterisk symbols on columns indicate differences between CTL and
MeHg. Asterisk symbols on brackets indicate significance between MeHg and SB+MeHg. **p < 0.01 (one-way ANOVA with Turkey’s post-hoc test).
was previously published (Sirabella et al., 2012; Formisano
et al., 2015b; Guida et al., 2015b, 2016). Instead, siSp4
significantly reduced Sp4 expression by 65%, whereas pBDNF
increased BDNF expression by 54%, both compared to the
respective control (Figures 5G,H). Intriguingly, transfection
of sip38, siSp1, siSp4, siHDAC4, and pBDNF significantly
reduced MeHg-induced cell death, as revealed by MTT assay
(Figure 5I).
DISCUSSION
The results of the present study showed that MeHg exposure
increased the expression of the HDAC4 isoform in SH-SY5Y
cells and that the stimulation of the P-p38/Sp1/Sp4 pathway
was the mechanism by which HDAC4 mRNA and protein
are up-regulated during MeHg exposure. In addition evidence
is provided that HDAC4 reduced the expression of its target
gene BDNF and that in cortical neurons treated for 24 h
with MeHg the knocking down of p38, Sp1, Sp4, and HDAC4
or the overexpression of BDNF caused a reduction of cell
death.
The most interesting result of this work is that HDAC4
is identified as a novel target of MeHg-induced neuronal
toxicity. In fact, MeHg exposure increased HDAC4 gene and
protein expression causing also in the nucleus an increase of
its binding to the BDNF gene promoter IV sequence with
consequent mRNA and protein reduction of this neuroprotective
factor. These results are in accordance with recent in vivo
studies demonstrating that intramuscular injection of the
organomercury compound thimerosal induces neuronal cell
death by increasing HDAC4 expression in rat prefrontal cortex
(Guida et al., 2015b, 2016), and that in cortical neurons
HDAC4 knockdown improves neuronal survival after oxygen
glucose deprivation (OGD, Yuan et al., 2016). Furthermore, we
found that of the three main branches of the MAPK cascade
(ERK, p38, and JNK), only p38 was involved in regulating
HDAC4 gene expression in cells exposed to MeHg. In fact,
MeHg increased p38 phosphorylation, but not that of ERK
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FIGURE 4 | MeHg increases HDAC4 binding on BDNF exon IV
promoter, by the p38/Sp1/Sp4 axis, determining its gene reduction. (A)
qRT-PCR of BDNF exon IV in SH-SY5Y treated with MeHg (1µM/24 h).
Graphs show quantification of ratio of BDNF exon IV to L19. Bars represent
mean ± S.E.M. obtained from three independent experiments. ***p < 0.001
(unpaired t-test). (B) ChIP analysis of the BDNF exon IV promoter regions
carried out with anti-HDAC4, in SH-SY5Y cells treated with MeHg (1µM/24 h).
The binding activity of HDAC4 is graphically represented as the percentage of
CTL. Each column represents the mean ± S.E.M (n = 3). *p < 0.05 (unpaired
t-test). (C) ChIP analysis of the BDNF exon IV promoter regions carried out
with anti-HDAC4, in SH-SY5Y cells treated with MeHg (1 µM/24 h), alone or in
combination with SB SB239063, and treated with MeHg and transfected with
siRNA for Sp1 (siSp1), Sp4 (siSp4), or HDAC4 (siHDAC4). The binding activity
of HDAC4 is graphically represented as the percentage of (CTL). Each column
represents the mean ± S.E.M (n = 3). Asterisk symbols on columns indicate
differences between control CTL and MeHg. Hashtag symbols on columns
indicate significance compared to MeHg. **p < 0.01, ##p < 0.01 (one-way
ANOVA with Turkey’s post-hoc test). (D) qRT-PCR of BDNF exon IV in
SH-SY5Y treated with MeHg (1 µM/24 h), alone or in combination with SB,
and treated with MeHg and transfected with siRNA for Sp1 (siSp1), Sp4
(siSp4), or HDAC4 (siHDAC4). Graphs show quantification of ratio of BDNF
exon IV to L19. Bars represent mean ± S.E.M. obtained from three
independent experiments. Asterisk symbols on columns indicate differences
between control CTL and MeHg. Hashtag symbols on columns indicate
significance compared to MeHg. *p < 0.05, #p < 0.05 (one-way ANOVA with
Turkey’s post-hoc test).
and JNK, and increased the expression of HDAC4 gene. This
hypothesis is straightened by the findings showing that when
cells were pretreated with the p38 inhibitor SB239063, the
MeHg-induced overexpression of HDAC4 was prevented. That
MeHg regulates p38, but not ERK and JNK, is partially in
agreement with other studies, where it has been found in
Neuro2A cell line that MeHg induced the phosphorylation
of ERK1/2 and p38, but not of JNK (Lu et al., 2011), and
that in SH-SY5Y cells p38 phosphorylation was stimulated
by MeHg, determining apoptotic cell death (Posser et al.,
2010).
The MeHg-induced HDAC4 up-regulation seems to occur
through the participation of the transcription factors Sp1 and
Sp4, since the expression of these proteins was increased
during MeHg exposure and HDAC4 increase was reverted by
silencing of these transcription factors. These findings, together
with those showing that the p38 inhibitor was not only able
to revert MeHg-induced overexpression of HDAC4 but also
that of Sp1 and Sp4, strongly suggest that the pathway P-
p38/Sp1/Sp4 is responsible for HDAC4 overexpression. These
results are in partial accordance with those obtained by Liu
et al. (2006), where they found that Sp1 and Sp3, by binding
HDAC4 promoter sequence, up-regulated HDAC4 expression
whereas, in our model, Sp4 and not Sp3 was modulated
after MeHg treatment. That Sp4 isoform, specifically expressed
in the brain (Suske, 1999), is regulated by p38 and its
increase up-regulates HDAC4 gene and protein expression after
MeHg exposure, to our knowledge, appears to be a novel
evidence.
The activation of HDAC4 triggered by MeHg is associated
with the down-regulation of its target gene BDNF and these
in vitro results are in line with those in vivo obtained by
Ceccatelli et al. (2013) that found a decrease of BDNF content
in the hippocampal DG of male mice born from mothers
exposed to MeHg. These results appear rather interesting since,
at molecular level, BDNF human and rat genes are very similar.
In particular BDNF gene is composed of eight 5-non-coding
exons and one 3-coding exon. Individual promoters control
the expression of each of the eight 5- exons, that splice with
the common exon 3 encoding for BDNF protein (He et al.,
2010). BDNF IV and VI exons are the most highly expressed
transcripts in humans, representing over 80% of the total
BDNF (Donnici et al., 2008). Interestingly, BDNF promoter IV
is known for its role in mediating activity-dependent BDNF
transcription (Tao et al., 1998) and it has been reported that
HDAC4 and HDAC5 repressed BDNF promoter IV activity in
cortical neurons (Koppel and Timmusk, 2013). It should be
underlined that in the present study, in line with the findings of
Koppel and Timmusk, we found an increase of HDAC4 binding
on the BDNF human promoter sequence IV in parallel with a
reduction of BDNF at level of the splicing isoform IV. The role
of HDAC4 in modulating the expression of BDNF following
MeHg exposure is confirmed by the data showing that siRNA
against HDAC4 blocked MeHg-induced BDNF gene and protein
decrease.
In cortical neurons we obtained results in line with those
obtained in SH-SY5Y cells and demonstrated that the pathway
p38/Sp1-Sp4/HDAC4/BDNF is responsible for MeHg-induced
neuronal death. In fact we found that this pathway is activated
after MeHg treatment (1 µM 24h) and that p38, Sp1, Sp4, and
HDAC4 silencing or BDNF overexpression partially reverted
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FIGURE 5 | MeHg by activating the p38/Sp1/Sp4/BDNF axis induced cell death in cortical neurons. (A) Effect of 24 h of MeHg (0.1, 0.5, 1, and 3 µM)
exposure on LDH release in cortical neurons. Bars represent the mean ± S.E.M. obtained in three independent experiments. Asterisk symbols on columns indicate
differences between CTL and MeHg treatment. Asterisk symbols on brackets indicate differences between MeHg groups. *p < 0.05, ****p < 0.0001 (one-way ANOVA
with Turkey’s post-hoc test). (B–F) Western blotting of P-p38, Sp1, Sp4, HDAC4, and BDNF in cortical neurons treated with 1 µM of MeHg for 24 h. Bars represent
the mean ± S.E.M. obtained from three independent experiments. Asterisk symbols on columns indicate differences between CTL and MeHg. **p < 0.01, *p < 0.05
(unpaired t-test). (G) Western blotting of BDNF in cortical neurons transfected for 24 h with plasmid overexpressing BDNF or with the empty vector (mock). Bars
represent the mean ± S.E.M. obtained from three independent experiments. * p < 0.05 (unpaired t-test). (H) Western blotting of Sp4 in cortical neurons transfected
for 24 h with a specific siRNA for Sp4 or with scramble (siCTL). Bars represent the mean ± S.E.M. obtained from three independent experiments. **p < 0.01
(unpaired t-test). (I) Effect of 24 h of MeHg (1 µM) exposure on LDH release in cortical neurons transfected with siRNAs for p38, Sp1, Sp4, and HDAC4 or with
pBDNF. Bars represent the mean ± S.E.M. obtained in three independent experiments. Asterisk symbols on columns indicate differences between CTL and MeHg
treatment. Hashtag symbols on columns indicate significance compared to MeHg. ##p < 0.01, #p < 0.05 (one-way ANOVA with Turkey’s post-hoc test).
FIGURE 6 | Schematic illustration of p38/Sp1/Sp4/HDAC4/BDNF
pathway activated by MeHg in cortical neurons.
MeHg-induced cell death, since ∼20% of the cells were rescued
and 50% remained dead, thus indicating that other pathways
could be involved.
It is noteworthy that in this study we evaluated MeHg
toxicity only in neurons, since glial inhibitor was added to the
incubation medium, in order to exclude a participation of glial
cells to MeHg toxic effect. In fact, it has been reported that
MeHg through glial cells modulates neurotoxicity by inhibiting
astrocytic glutamate uptake, and stimulating glutamate eﬄux that
causes an increase of glutamate in the synapse and, consequently
cell death (Ni et al., 2011). The concentration of MeHg used
for the experiments in cortical neurons was the same used
in neuroblastoma cells experiments and also in other studies
(Fujimura and Usuki, 2012). The neurotoxic role of p38, Sp1, and
HDAC4 and the neuroprotective role of BDNF is already known.
Indeed: (1) stimulation of the p38 signaling pathways contributes
to neuronal cell death (Xia et al., 1995); (2) Sp1 knockdown
improves survival in cellular and animal models of Huntington’s
disease (Qiu et al., 2006) or after PCB exposure (Formisano
et al., 2015c); (3) inactivation of HDAC4 by small interfering
RNA reduced neuronal cell death to potassium withdrawal
(Bolger and Yao, 2005) or after OGD (Yuan et al., 2016); (4)
BDNF treatment concurrent with Aβ1–42 exposure prevented
neuron death (Nagahara et al., 2009). However, the results of
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the present study may represent a novelty in identifying for
the first time the neurotoxicity of Sp4 isoform, as demonstrated
by the fact that its knocking-down in cortical neurons reduced
MeHg-induced cell death and in proving the involvement of
p38/Sp1/Sp4/HDAC4/BDNF chain in eliciting the neurotoxic
effects of MeHg (Figure 6).
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